ANNUAL REPORTS
Oregon Bio’s 2016-2017 Annual Report. We’re excited to share Oregon Bio’s activities and initiatives over the past year, highlighting successes of significant investments in the association and the industry. In this report, you can read updates about the companies who won the coveted pitch showcase and researchers who were recognized by esteemed judges. You can also catch the latest on the unprecedented grant from the Oregon Talent Council, the new tools Oregon Bio has to assist members, and the overview of our advocacy and outreach work.
And, here are expanded articles to tell the ‘rest of the story.’ These articles parallel the briefs included in the annual report, for a little deeper dive into the current happenings and member benefits of the Oregon Bioscience Association. Note, we also are sharing a special article that is ‘Web only,’ which means it’s only available here!
WEB EXCLUSIVES:
OTRADI Bioscience Incubator Creates Smart Health Annex for Digital Health Startups: pdf, article
Oregon Bio Offers New Member-Friendly Web Design, New CRM: pdf, article
Oregon’s Bio Talent Pool Boosted by Innovative Grant: pdf, article
Annual Conference Tops Attendance; Focuses on Emerging Researchers and Company Showcase: pdf, article
Web Only: Making Internal Processes More Efficient, Bio Staff Creates Time to Focus On Members: pdf, article
Previous Annual Reports
2015
2014
2013
2012
OREGON’S ECONOMIC IMPACT
Executive Summary
Final Report
Released in 2016. Oregon’s biotechnology and life science sector continues its steady and significant growth.
The new economic impact study shows bioscience in Oregon generates high-paying jobs, while bringing new money to the state through domestic and international exports. In 2014, the direct economic activity associated with Oregon’s bioscience industry includes:
- 17,874 jobs and $1.3 billion in total wages,
- An average annual wage of $74,188, which is 62 percent greater than the statewide average wage for private sector employment,
- $3.8 billion in exports, and
- $171.5 million in state and local taxes paid by bioscience firms and their employees.
Read the press release.
